Fort Washington Investment Advisors Inc. OH cut its position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 12.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 224,911 shares of the company’s stock after selling 32,730 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Doximity were worth $16,452,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of DOCS. Strs Ohio bought a new stake in shares of Doximity in the first quarter worth $665,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Doximity in the second quarter valued at $1,628,000. Dynamic Technology Lab Private Ltd acquired a new stake in Doximity in the 1st quarter valued at $801,000. Empowered Funds LLC lifted its position in Doximity by 118.8% during the 1st quarter. Empowered Funds LLC now owns 123,304 shares of the company’s stock worth $7,155,000 after buying an additional 66,947 shares in the last quarter. Finally, Allworth Financial LP boosted its stake in shares of Doximity by 1,448.7% during the 2nd quarter. Allworth Financial LP now owns 8,719 shares of the company’s stock worth $535,000 after buying an additional 8,156 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.
Analyst Ratings Changes
DOCS has been the topic of a number of recent research reports. Canaccord Genuity Group lowered their target price on Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $75.00 to $82.00 in a research report on Monday, October 27th. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $62.00 price objective on shares of Doximity in a research note on Friday, October 10th. BMO Capital Markets started coverage on Doximity in a report on Thursday, November 13th. They issued a “market perform” rating and a $55.00 price objective for the company. Finally, The Goldman Sachs Group set a $64.00 target price on shares of Doximity and gave the stock a “sell” rating in a report on Wednesday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Doximity presently has a consensus rating of “Moderate Buy” and an average target price of $68.94.
Doximity Trading Up 0.7%
Shares of NASDAQ DOCS opened at $44.56 on Wednesday. The company has a market capitalization of $8.39 billion, a P/E ratio of 44.56, a P/E/G ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 12 month low of $43.25 and a 12 month high of $85.21. The stock has a 50 day moving average of $51.98 and a 200-day moving average of $60.52.
Doximity (NASDAQ:DOCS – Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the prior year, the business posted $0.30 earnings per share. The firm’s revenue was up 23.2% on a year-over-year basis. Analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.
Insider Transactions at Doximity
In related news, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at approximately $1,318,103.16. This trade represents a 9.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 31.30% of the company’s stock.
About Doximity
Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”
The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.
Read More
- Five stocks we like better than Doximity
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
